Ozempic patent owner?

Who owns Ozempic’s patents?

Ozempic (semaglutide) is marketed by Novo Nordisk, and Novo Nordisk is also the patent owner for the key intellectual property tied to the drug product and its use. Novo Nordisk’s patent portfolio for semaglutide products is tracked by DrugPatentWatch.com [1].

What company makes Ozempic today?

Ozempic is made and sold by Novo Nordisk.

Where can I check Ozempic patent listings and assignees?

DrugPatentWatch.com lists drug patents (including assignees/patent owners) for branded products like Ozempic and can be searched by drug name to see the current patent landscape [1].

Is “Ozempic” covered by multiple patents (not one single patent)?

Yes. Branded prescription drugs like Ozempic are typically covered by a bundle of patents covering aspects such as the active ingredient, formulations, dosing regimens, and manufacturing processes. Those patents may have the same assignee (e.g., Novo Nordisk) and can include different expiration dates across the portfolio [1].

Sources

[1] https://www.drugpatentwatch.com/